{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T05:57:43Z","timestamp":1757311063127,"version":"3.44.0"},"reference-count":134,"publisher":"The Pediatric Pharmacy Association","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9]]},"abstract":"The severe respiratory disease COVID-19 (coronavirus disease 2019) was first reported in late December 2019 in Wuhan City, China. Soon thereafter, the World Health Organization (WHO) officially declared it a pandemic. The adult population is highly affected by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2); however, infants and children are also not spared. Transmission in the pediatric population appears to be primarily from COVID-19\u2013positive adults, largely from family contacts through droplets, direct contacts, and aerosols. There is also evidence of fecal-oral route of transmission. The incubation period of COVID-19 in children ranges from 2 to 10 days. Most children are asymptomatic. The most common symptoms amongst symptomatic children are fever and cough. Shortness of breath, sore throat, rhinorrhea, conjunctivitis, fatigue, and headache are other common symptoms. Diarrhea, vomiting, and abdominal pain are the common gastrointestinal symptoms that may be present with or without respiratory symptoms. Very few children are likely to develop severe disease.Supportive care is the mainstay of treatment. Though data are limited, antiviral therapies such as remdesivir, favipiravir, lopinavir\/ritonavir, and other drugs like hydroxychloroquine\/chloroquine have been used for severe COVID-19 cases, with remdesivir showing the greatest promise. A few children may develop an exaggerated immune response, characterized by exaggerated cytokine release and manifests with features similar to Kawasaki disease. The syndrome has been referred to by many names including pediatric inflammatory multisystem syndrome<\/jats:italic> (PIMS) and more recently, as multisystem inflammatory syndrome in children<\/jats:italic> (MIS-C); this life-threatening condition often requires a multidisciplinary team effort and use of immunomodulators.<\/jats:p>","DOI":"10.5863\/1551-6776-25.7.574","type":"journal-article","created":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T23:36:34Z","timestamp":1601422594000},"page":"574-585","source":"Crossref","is-referenced-by-count":18,"title":["COVID-19 Pandemic and Children: A Review"],"prefix":"10.5863","volume":"25","author":[{"given":"Vinay","family":"Rathore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhiruchi","family":"Galhotra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul","family":"Pal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamal Kant","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3883","reference":[{"issue":"11","key":"i1551-6776-25-7-574-b1","series-title":"Ann Transl Med","doi-asserted-by":"publisher","first-page":"694","DOI":"10.21037\/atm-20-2793","article-title":"Trajectory of the COVID-19 pandemic: chasing a moving target","volume":"8","year":"2020","unstructured":"Sahu\n KK\n , MishraAK, LalA.\n Trajectory of the COVID-19 pandemic: chasing a moving target. Ann Transl Med. 2020;8(11):694. doi:10.21037\/atm-20-2793"},{"article-title":"Coronavirus disease (COVID-2019) situation reports","year":"2020","key":"i1551-6776-25-7-574-b2","unstructured":"World Health Organization.\n Coronavirus disease (COVID-2019) situation reports. 2020. Accessed June 24, 2020. https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/situation-reports"},{"issue":"13","key":"i1551-6776-25-7-574-b3","series-title":"JAMA","first-page":"1239","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention","volume":"323","year":"2020","unstructured":"Wu\n Z\n , McGooganJM.\n Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239\u20131242."},{"key":"i1551-6776-25-7-574-b4","unstructured":"US Centers for Disease Control and Prevention.\n Cases in theU.S.\n Atlanta, GA. Accessed June 20, 2020. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/cases-updates\/cases-in-us.html","article-title":"Cases in theU.S."},{"issue":"4","key":"i1551-6776-25-7-574-b5","series-title":"J Family Med Prim Care","first-page":"1784","article-title":"Current perspective on pandemic of COVID-19 in the United States","volume":"9","year":"2020","unstructured":"Sahu\n KK\n , KumarR.\n Current perspective on pandemic of COVID-19 in the United States. J Family Med Prim Care. 2020;9(4):1784\u20131791."},{"issue":"6","key":"i1551-6776-25-7-574-b6","series-title":"Ann Transl Med","doi-asserted-by":"publisher","first-page":"393","DOI":"10.21037\/atm.2020.02.92","article-title":"Comprehensive update on current outbreak of novel coronavirus infection (2019-nCoV)","volume":"8","year":"2020","unstructured":"Sahu\n KK\n , MishraAK, LalA.\n Comprehensive update on current outbreak of novel coronavirus infection (2019-nCoV). Ann Transl Med. 2020;8(6):393. doi:10.21037\/atm.2020.02.92"},{"issue":"5","key":"i1551-6776-25-7-574-b7","series-title":"Pediatr Infect Dis J","first-page":"355","article-title":"Coronavirus infections in children including COVID-19: an overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children","volume":"39","year":"2020","unstructured":"Zimmermann\n P\n , CurtisN.\n Coronavirus infections in children including COVID-19: an overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children. Pediatr Infect Dis J. 2020;39(5):355\u2013368."},{"issue":"8","key":"i1551-6776-25-7-574-b8","series-title":"New Engl J Med","first-page":"727","article-title":"A Novel coronavirus from patients with pneumonia in China, 2019","volume":"382","year":"2020","unstructured":"Zhu\n N\n , ZhangD, WangW, \n et al. A Novel coronavirus from patients with pneumonia in China, 2019. New Engl J Med. 2020;382(8):727\u2013733."},{"issue":"8","key":"i1551-6776-25-7-574-b9","series-title":"New Engl J Med","first-page":"760","article-title":"Another decade, another coronavirus","volume":"382","year":"2020","unstructured":"Perlman\n S.\n \n \n Another decade, another coronavirus. New Engl J Med. 2020;382(8):760\u2013762."},{"issue":"2","key":"i1551-6776-25-7-574-b10","series-title":"Monaldi Arch Chest Dis","doi-asserted-by":"publisher","DOI":"10.4081\/monaldi.2020.1341","article-title":"Cerebrovascular events in COVID-19 patients","volume":"90","year":"2020","unstructured":"Mishra\n AK\n , SahuKK, GeorgeAA, \n et al. Cerebrovascular events in COVID-19 patients. Monaldi Arch Chest Dis. 2020;90(2):10.4081\/monaldi.2020.1341. doi:10.4081\/monaldi.2020.1341"},{"key":"i1551-6776-25-7-574-b11","series-title":"Cardiovasc Pathol","doi-asserted-by":"publisher","first-page":"107246","DOI":"10.1016\/j.car-path.2020.107246","article-title":"Cardiovascular factors predicting poor outcome in COVID-19 patients","volume":"49","year":"2020","unstructured":"Mishra\n AK\n , LalA, SahuKK, \n et al. Cardiovascular factors predicting poor outcome in COVID-19 patients. Cardiovasc Pathol. 2020;49:107246. doi:10.1016\/j.car-path.2020.107246"},{"issue":"2","key":"i1551-6776-25-7-574-b12","series-title":"Childs Health","first-page":"133","article-title":"Pathogenesis of COVID-19","volume":"15","year":"2020","unstructured":"Abaturov\n AE\n , AgafonovaEA, KrivushaEL, \n et al. Pathogenesis of COVID-19. Childs Health. 2020;15(2):133\u2013144."},{"issue":"1","key":"i1551-6776-25-7-574-b13","series-title":"Monaldi Arch Chest Dis","doi-asserted-by":"publisher","DOI":"10.4081\/monaldi.2020.1292","article-title":"COVID-2019: update on epidemiology, disease spread and management","volume":"90","year":"2020","unstructured":"Sahu\n KK\n , MishraAK, LalA.\n COVID-2019: update on epidemiology, disease spread and management. Monaldi Arch Chest Dis. 2020;90(1):10.4081\/monaldi.2020.1292. doi:10.4081\/monaldi.2020.1292"},{"issue":"3","key":"i1551-6776-25-7-574-b14","series-title":"J Microbiol Immunol Infect","first-page":"371","article-title":"Are children less susceptible to COVID-19?","volume":"53","year":"2020","unstructured":"Lee\n PI\n , HuYL, ChenPY, \n et al. Are children less susceptible to COVID-19?J Microbiol Immunol Infect. 2020;53(3):371\u2013372."},{"key":"i1551-6776-25-7-574-b15","series-title":"Clin Immunol","doi-asserted-by":"publisher","first-page":"108427","DOI":"10.1016\/j.clim.2020.108427","article-title":"COVID-19 pathophysiology: areview","volume":"215","year":"2020","unstructured":"Yuki\n K\n , FujiogiM, KoutsogiannakiS.\n COVID-19 pathophysiology: areview. Clin Immunol. 2020;215:108427. doi:10.1016\/j.clim.2020.108427"},{"issue":"2","key":"i1551-6776-25-7-574-b16","series-title":"J Travel Med","doi-asserted-by":"publisher","first-page":"taaa021","DOI":"10.1093\/jtm\/taaa021","article-title":"The reproductive number of COVID-19 is higher compared to SARS coronavirus","volume":"27","year":"2020","unstructured":"Liu\n Y\n , GayleAA, Wilder-SmithA, \n et al. The reproductive number of COVID-19 is higher compared to SARS coronavirus. J Travel Med. 2020;27(2):taaa021. doi:10.1093\/jtm\/taaa021"},{"issue":"12","key":"i1551-6776-25-7-574-b17","series-title":"New Engl J Med","first-page":"1177","article-title":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients","volume":"382","year":"2020","unstructured":"Zou\n L\n , RuanF, HuangM, \n et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. New Engl J Med. 2020;382(12):1177\u20131179."},{"issue":"5","key":"i1551-6776-25-7-574-b18","series-title":"Lancet Infect Dis","first-page":"565","article-title":"Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARSCoV-2: an observational cohort study","volume":"20","year":"2020","unstructured":"To\n KK\n , TsangOT, LeungWS, \n et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARSCoV-2: an observational cohort study. Lancet Infect Dis. 2020;20(5):565\u2013574."},{"issue":"7809","key":"i1551-6776-25-7-574-b19","series-title":"Nature","first-page":"465","article-title":"Virological assessment of hospitalized patients with COVID-2019","volume":"581","year":"2020","unstructured":"W\u00f6lfel\n R\n , CormanVM, GuggemosW, \n et al. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020;581(7809):465\u2013469."},{"issue":"5","key":"i1551-6776-25-7-574-b20","series-title":"Nat Med","first-page":"672","article-title":"Temporal dynamics in viral shedding and transmissibility of COVID-19","volume":"26","year":"2020","unstructured":"He\n X\n , LauEHY, WuP, \n et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med. 2020;26(5):672\u2013675."},{"issue":"6","key":"i1551-6776-25-7-574-b21","series-title":"Nat Med","first-page":"861","article-title":"Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States","volume":"26","year":"2020","unstructured":"Kujawski\n STC\n , WongKK, CollinsJP, ; COVID-19 Investigation Team.\n Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States. Nat Med. 2020;26(6):861\u2013868."},{"issue":"10223","key":"i1551-6776-25-7-574-b22","series-title":"Lancet","first-page":"514","article-title":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster","volume":"395","year":"2020","unstructured":"Chan\n JF-W\n , YuanS, KokK-H, \n et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514\u2013523."},{"key":"i1551-6776-25-7-574-b23","series-title":"Zhonghua Er Ke Za Zhi [in Chinese]","doi-asserted-by":"publisher","first-page":"E001","DOI":"10.3760\/cma.j.issn.0578-1310.2020.0001","article-title":"Facing the pandemic of 2019 novel coronavirus infections: the pediatric perspectives","volume":"58","year":"2020","unstructured":"Fang\n F\n , LuoXP.\n Facing the pandemic of 2019 novel coronavirus infections: the pediatric perspectives. Zhonghua Er Ke Za Zhi [in Chinese]. 2020;58:E001. doi: 10.3760\/cma.j.issn.0578-1310.2020.0001"},{"issue":"11","key":"i1551-6776-25-7-574-b24","series-title":"N Engl J Med","first-page":"1070","article-title":"A locally transmitted case of SARS-CoV-2 infection in Taiwan","volume":"382","year":"2020","unstructured":"Liu\n Y-C\n , LiaoC-H, ChangC-F, \n et al. A locally transmitted case of SARS-CoV-2 infection in Taiwan. N Engl J Med. 2020;382(11):1070\u20131072."},{"issue":"14","key":"i1551-6776-25-7-574-b25","series-title":"JAMA","first-page":"1406","article-title":"Presumed asymptomatic carrier transmission of COVID-19","volume":"323","year":"2020","unstructured":"Bai\n Y\n , YaoL, WeiT, \n et al. Presumed asymptomatic carrier transmission of COVID-19. JAMA. 2020;323(14):1406\u20131407."},{"issue":"10","key":"i1551-6776-25-7-574-b26","series-title":"N Engl J Med","first-page":"970","article-title":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany","volume":"382","year":"2020","unstructured":"Rothe\n C\n , SchunkM, SothmannP, \n et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med. 2020;382(10):970\u2013971."},{"issue":"11","key":"i1551-6776-25-7-574-b27","series-title":"J Infect Dis","first-page":"1757","article-title":"A familial cluster of infection associated with the 2019 novel coronavirus indicating possible person-to-person transmission during the incubation period","volume":"221","year":"2020","unstructured":"Yu\n P\n , ZhuJ, ZhangZ, \n et al. A familial cluster of infection associated with the 2019 novel coronavirus indicating possible person-to-person transmission during the incubation period. J Infect Dis. 2020;221(11):1757\u20131761."},{"issue":"4","key":"i1551-6776-25-7-574-b28","series-title":"Nat Med","first-page":"502","article-title":"Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding","volume":"26","year":"2020","unstructured":"Xu\n Y\n , LiX, ZhuB, \n et al. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding. Nat Med. 2020;26(4):502\u2013505."},{"issue":"1","key":"i1551-6776-25-7-574-b29","series-title":"Gastroenterology","first-page":"81","article-title":"Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from the Hong Kong cohort: systematic review and Meta-analysis","volume":"159","year":"2020","unstructured":"Cheung\n KS\n , HungIF, ChanPP, \n et al. Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from the Hong Kong cohort: systematic review and Meta-analysis. Gastroenterology. 2020;159(1):81\u201395."},{"issue":"10223","key":"i1551-6776-25-7-574-b30","series-title":"Lancet","first-page":"507","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","year":"2020","unstructured":"Chen\n N\n , ZhouM, DongX, \n et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507\u2013513."},{"issue":"6","key":"i1551-6776-25-7-574-b31","series-title":"J Med Virol","first-page":"680","article-title":"Fecal specimen diagnosis 2019 novel coronavirus-infected pneumonia","volume":"92","year":"2020","unstructured":"Zhang\n J\n , WangS, XueY.\n Fecal specimen diagnosis 2019 novel coronavirus-infected pneumonia. J Med Virol. 2020;92(6):680\u2013682."},{"issue":"9","key":"i1551-6776-25-7-574-b32","series-title":"Chin Med J (Engl)","first-page":"1039","article-title":"Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients","volume":"133","year":"2020","unstructured":"Ling\n Y\n , XuSB, LinYX, \n et al. Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients. Chin Med J (Engl). 2020;133(9):1039\u20131043."},{"issue":"6","key":"i1551-6776-25-7-574-b33","series-title":"Gastroenterology","first-page":"1831","article-title":"Evidence for gastrointestinal infection of SARS-CoV-2","volume":"158","year":"2020","unstructured":"Xiao\n F\n , TangM, ZhengX, \n et al. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology. 2020;158(6):1831\u20131833."},{"issue":"10226","key":"i1551-6776-25-7-574-b34","series-title":"Lancet","first-page":"809","article-title":"Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records","volume":"395","year":"2020","unstructured":"Chen\n H\n , GuoJ, WangC, \n et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020;395(10226):809\u2013815."},{"issue":"1","key":"i1551-6776-25-7-574-b35","series-title":"Transl Pediatr","first-page":"51","article-title":"Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia","volume":"9","year":"2020","unstructured":"Zhu\n H\n , WangL, FangC, \n et al. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Transl Pediatr. 2020;9(1):51\u201360."},{"issue":"8","key":"i1551-6776-25-7-574-b36","series-title":"JAMA","first-page":"707","article-title":"Coronavirus infections\u2014more than just the common cold","volume":"323","year":"2020","unstructured":"Paules\n CI\n , MarstonHD, FauciAS.\n Coronavirus infections\u2014more than just the common cold. JAMA. 2020;323(8):707\u2013708."},{"key":"i1551-6776-25-7-574-b37","series-title":"J Med Virol","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25784","article-title":"A twin challenge to handle: COVID-19 with pregnancy [published online ahead of print April 5, 2020].","unstructured":"Sahu\n KK\n , MishraAK, LalA.\n A twin challenge to handle: COVID-19 with pregnancy [published online ahead of print April 5, 2020].\n J Med Virol. doi:10.1002\/jmv.25784"},{"issue":"8","key":"i1551-6776-25-7-574-b38","series-title":"BJOG","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1111\/1471-0528.16257","article-title":"Re: From the frontlines of COVID-19\u2014how prepared are we as obstetricians: commentary","volume":"127","year":"2020","unstructured":"Sahu\n KK\n , MishraAK, LalA.\n Re: From the frontlines of COVID-19\u2014how prepared are we as obstetricians: commentary. BJOG. 2020;127(8):1041. doi:10.1111\/1471-0528.16257"},{"key":"i1551-6776-25-7-574-b39","unstructured":"American College of Obstetricians and Gynecologists [ACOG]\n \n Clinical Guidelines for practices advisory for management of patients with confirmed coronavirus diseases.\n Accessed June 27, 2020. https:\/\/www.acog.org\/clinical\/clinical-guidance\/practice-advisory\/articles\/2020\/03\/novel-coronavirus-2019","article-title":"Clinical Guidelines for practices advisory for management of patients with confirmed coronavirus diseases."},{"key":"i1551-6776-25-7-574-b40","series-title":"SSRN Journal","doi-asserted-by":"publisher","first-page":"20044826","DOI":"10.11 01\/2020.03.26.20044826","article-title":"Children are unlikely to have been the primary source of household SARS-CoV-2 infections. Preprint.Posted online March 30","year":"2020","unstructured":"Zhu\n Y\n , BloxhamCJ, HulmeKD, \n et al. Children are unlikely to have been the primary source of household SARS-CoV-2 infections. Preprint.Posted online March 30. SSRN Journal2020;20044826. doi:10.11 01\/2020.03.26.20044826"},{"issue":"2","key":"i1551-6776-25-7-574-b41","series-title":"Pediatrics","doi-asserted-by":"publisher","first-page":"e20201576","DOI":"10.1542\/peds.2020-1576","article-title":"COVID-19 in children and the dynamics of infection in families","volume":"146","year":"2020","unstructured":"Posfay-Barbe\n C\n , WagnerN, GautheyM,\n et al. COVID-19 in children and the dynamics of infection in families. Pediatrics. 2020;146(2):e20201576. doi:10.1542\/peds.2020-1576"},{"key":"i1551-6776-25-7-574-b42","series-title":"Clin Infect Dis","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa450","article-title":"The characteristics of household transmission of COVID-19 [published online ahead of print April 17, 2020].","unstructured":"Li\n W\n , ZhangB, LuJ, \n et al. The characteristics of household transmission of COVID-19 [published online ahead of print April 17, 2020].Clin Infect Dis. doi:10.1093\/cid\/ciaa450"},{"issue":"8","key":"i1551-6776-25-7-574-b43","series-title":"Lancet Infect Dis","first-page":"911","article-title":"Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study","volume":"20","year":"2020","unstructured":"Bi\n Q\n , WuY, MeiS, \n et al. Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study. Lancet Infect Dis. 2020;20(8):911\u2013919."},{"key":"i1551-6776-25-7-574-b44","unstructured":"National Centre for Immunisation Research and Surveillance.\n Report: COVID-19 in schools: the experience in NSW [Internet].\n Cited May 29, 2020. Accessed July 19, 2020. http:\/\/ncirs.org.au\/covid-19-in-schools","article-title":"Report: COVID-19 in schools: the experience in NSW [Internet]."},{"issue":"7","key":"i1551-6776-25-7-574-b45","series-title":"Arch Dis Child","first-page":"618","article-title":"Children are not COVID-19 super spreaders: time to go back to school","volume":"105","year":"2020","unstructured":"Munro\n APS\n , FaustSN.\n Children are not COVID-19 super spreaders: time to go back to school. Arch Dis Child. 2020;105(7):618\u2013619."},{"issue":"10225","key":"i1551-6776-25-7-574-b46","series-title":"Lancet","first-page":"689","article-title":"Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study","volume":"395","year":"2020","unstructured":"Wu\n JT\n , LeungK, LeungGM.\n Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet. 2020;395(10225):689\u2013697."},{"issue":"5","key":"i1551-6776-25-7-574-b47","series-title":"J Med Virol","first-page":"476","article-title":"Does SARS-CoV-2 has a longer incubation period than SARS and MERS?","volume":"92","year":"2020","unstructured":"Jiang\n X\n , RaynerS, LuoM.\n Does SARS-CoV-2 has a longer incubation period than SARS and MERS?\n J Med Virol.2020;92(5):476\u2013478."},{"issue":"6","key":"i1551-6776-25-7-574-b48","series-title":"Acta Paediatr","first-page":"1088","article-title":"Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults","volume":"109","year":"2020","unstructured":"Ludvigsson\n JF.\n \n \n Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. 2020;109(6):1088\u20131095."},{"issue":"7","key":"i1551-6776-25-7-574-b49","series-title":"J Med Virol","first-page":"747","article-title":"COVID-19 epidemic: disease characteristics in children","volume":"92","year":"2020","unstructured":"She\n J\n , LiuL, LiuW.\n COVID-19 epidemic: disease characteristics in children. J Med Virol. 2020;92(7):747\u2013754."},{"issue":"6","key":"i1551-6776-25-7-574-b50","series-title":"Pediatrics","doi-asserted-by":"publisher","first-page":"e20200702","DOI":"10.1542\/peds.2020-0702 32179660","article-title":"Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China","volume":"145","year":"2020","unstructured":"Dong\n Y\n , MoX, HuY, \n et al. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. Pediatrics. 2020;145(6):e20200702. doi: 10.1542\/peds.2020-0702 32179660"},{"key":"i1551-6776-25-7-574-b51","series-title":"MMWR Morb Mortal Wkly Rep","first-page":"422","article-title":"Coronavirus disease 2019 in children\u2014United States, February 12\u2013April 2, 2020","volume":"69","year":"2020","unstructured":"C D C COVID-19 Response Team.\n Coronavirus disease 2019 in children\u2014United States, February 12\u2013April 2, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:422\u2013426."},{"issue":"6","key":"i1551-6776-25-7-574-b52","series-title":"Pediatrics","doi-asserted-by":"publisher","first-page":"e20200702","DOI":"10.1542\/peds.2020-0702","article-title":"Epidemiology of COVID-19 among children in China","volume":"145","year":"2020","unstructured":"Dong\n Y\n , MoX, HuY, \n et al. Epidemiology of COVID-19 among children in China. Pediatrics. 2020;145(6):e20200702. doi:10.1542\/peds.2020-0702"},{"issue":"3","key":"i1551-6776-25-7-574-b53","series-title":"World J Pediatr","first-page":"223","article-title":"Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts' consensus statement","volume":"16","year":"2020","unstructured":"Shen\n K\n , YangY, WangT, \n et al. Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts' consensus statement. World J Pediatr. 2020;16(3):223\u2013231."},{"key":"i1551-6776-25-7-574-b54","series-title":"Zhonghua Er Ke Za Zhi","doi-asserted-by":"publisher","first-page":"E008","DOI":"10.3760\/cma.j.issn.0578-1310.2020.0008","article-title":"Retracted: Clinical and epidemiological characteristics of 34 children with 2019 novel coronavirus infection in Shenzhen","volume":"58","year":"2020","unstructured":"Wang\n XF\n , YuanJ, ZhengYJ, \n et al. Retracted: Clinical and epidemiological characteristics of 34 children with 2019 novel coronavirus infection in Shenzhen. Zhonghua Er Ke Za Zhi. 2020;58:E008. doi: 10.3760\/cma.j.issn.0578-1310.2020.0008"},{"issue":"17","key":"i1551-6776-25-7-574-b55","series-title":"N Engl J Med","first-page":"1663","article-title":"SARS-CoV-2 infection in children","volume":"382","year":"2020","unstructured":"Lu\n X\n , ZhangL, DuH, \n et al. SARS-CoV-2 infection in children. N Engl J Med. 2020;382(17):1663\u20131665."},{"issue":"9","key":"i1551-6776-25-7-574-b56","series-title":"Aliment Pharmacol Ther","first-page":"843","article-title":"Gastrointestinal features in COVID-19 and the possibility of faecal transmission","volume":"51","year":"2020","unstructured":"Tian\n Y\n , RongL, NianW, \n et al. Gastrointestinal features in COVID-19 and the possibility of faecal transmission. Aliment Pharmacol Ther. 2020;51(9):843\u2013851."},{"issue":"2","key":"i1551-6776-25-7-574-b57","series-title":"Arch Acad Emerg Med","first-page":"667","article-title":"Chilblains are a common cutaneous finding during the COVID-19 pandemic: a retrospective nationwide study from France","volume":"83","year":"2020","unstructured":"de Masson\n A\n , BouazizJD, SulimovicL, \n et al. Chilblains are a common cutaneous finding during the COVID-19 pandemic: a retrospective nationwide study from France. Arch Acad Emerg Med. 2020;83(2):667\u2013670."},{"issue":"1","key":"i1551-6776-25-7-574-b58","series-title":"Arch Acad Emerg Med","first-page":"e50","article-title":"Clinical characteristics of COVID-19 infection in newborns and pediatrics: a systematic review","volume":"8","year":"2020","unstructured":"Panahi\n L\n , AmiriM, PouyS.\n Clinical characteristics of COVID-19 infection in newborns and pediatrics: a systematic review. Arch Acad Emerg Med. 2020;8(1):e50."},{"issue":"11","key":"i1551-6776-25-7-574-b59","series-title":"JAMA","first-page":"1061","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus\u2013infected pneumonia in Wuhan, China","volume":"323","year":"2020","unstructured":"Wang\n D\n , HuB, HuC, \n et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus\u2013infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061\u20131069."},{"issue":"20","key":"i1551-6776-25-7-574-b60","series-title":"JAMA","first-page":"2052","article-title":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area","volume":"323","year":"2020","unstructured":"Richardson\n S\n , HirschJS, NarasimhanM, \n et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323(20):2052\u20132059."},{"key":"i1551-6776-25-7-574-b61","series-title":"BMJ","doi-asserted-by":"publisher","first-page":"m1966","DOI":"10.1136\/bmj.m1966","article-title":"Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study","volume":"369","year":"2020","unstructured":"Petrilli\n CM\n , JonesSA, YangJ, \n et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 2020;369:m1966. doi:10.1136\/bmj.m1966"},{"issue":"4","key":"i1551-6776-25-7-574-b62","series-title":"Indian J Pediatr","first-page":"281","article-title":"A review of coronavirus disease-2019 (COVID-19)","volume":"87","year":"2020","unstructured":"Singhal\n T.\n \n \n A review of coronavirus disease-2019 (COVID-19). Indian J Pediatr. 2020;87(4):281\u2013286."},{"key":"i1551-6776-25-7-574-b63","unstructured":"World Health Organization.Director-General's opening remarks at the media briefing on COVID-19.Accessed August 10, 2020. https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/transcripts\/who-audio-emergencies-coronavirus-press-conference-11may2020.pdf?sfvrsn=4f78bd0_0","article-title":"Director-General's opening remarks at the media briefing on COVID-19."},{"issue":"5","key":"i1551-6776-25-7-574-b64","series-title":"JCO Oncol Pract","first-page":"223","article-title":"Managing COVID-19 in patients with cancer: a double blow for oncologists","volume":"16","year":"2020","unstructured":"Sahu\n KK\n , JindalV, SiddiquiAD.\n Managing COVID-19 in patients with cancer: a double blow for oncologists. JCO Oncol Pract. 2020;16(5):223\u2013225."},{"issue":"7","key":"i1551-6776-25-7-574-b65","series-title":"Med Oncol","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s12032-020-01382-w","article-title":"Cancer treatment during COVID-19 pandemic","volume":"37","year":"2020","unstructured":"Jindal\n V\n , SahuKK, GaikazianS, \n et al. Cancer treatment during COVID-19 pandemic. Med Oncol. 2020;37(7):58. doi:10.1007\/s12032-020-01382-w"},{"issue":"7","key":"i1551-6776-25-7-574-b66","series-title":"Acta Obstet Gynecol Scand","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1111\/aogs.13850","article-title":"COVID-2019 and pregnancy: a plea for transparent reporting of all cases","volume":"99","year":"2020","unstructured":"Sahu\n KK\n , LalA, MishraAK.\n COVID-2019 and pregnancy: a plea for transparent reporting of all cases. Acta Obstet Gynecol Scand. 2020;99(7):951. doi:10.1111\/aogs.13850"},{"key":"i1551-6776-25-7-574-b67","series-title":"JAMA Pediatr","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2020.1948","article-title":"Characteristics and outcomes of children with coronavirus disease 2019 (COVID-19) infection admitted to US and Canadian pediatric intensive care units [published online ahead of print May 11, 2020].","unstructured":"Shekerdemian\n LS\n , MahmoodNR, WolfeKK, \n et al. Characteristics and outcomes of children with coronavirus disease 2019 (COVID-19) infection admitted to US and Canadian pediatric intensive care units [published online ahead of print May 11, 2020].JAMA Pediatr. doi:10.1001\/jamapediatrics.2020.1948"},{"issue":"2","key":"i1551-6776-25-7-574-b68","series-title":"Br J Haematol","first-page":"e86","article-title":"Managing sickle cell patients with COVID-19 infection: the need to pool our collective experience","volume":"190","year":"2020","unstructured":"Sahu\n KK\n , SiddiquiAD, CernyJ.\n Managing sickle cell patients with COVID-19 infection: the need to pool our collective experience. Br J Haematol. 2020;190(2):e86\u2013e89."},{"issue":"8","key":"i1551-6776-25-7-574-b69","series-title":"Am J Hematol","first-page":"E213","article-title":"From hematologist's desk: the effect of COVID-19 on the blood system","volume":"95","year":"2020","unstructured":"Sahu\n KK\n , SiddiquiAD.\n From hematologist's desk: the effect of COVID-19 on the blood system. Am J Hematol. 2020;95(8):E213\u2013E215."},{"issue":"7","key":"i1551-6776-25-7-574-b70","series-title":"Clin Chem Lab Med","first-page":"1135","article-title":"Laboratory abnormalities in children with novel coronavirus disease 2019","volume":"58","year":"2020","unstructured":"Henry\n BM\n , LippiG, PlebaniM.\n Laboratory abnormalities in children with novel coronavirus disease 2019. Clin Chem Lab Med. 2020;58(7):1135\u20131138."},{"issue":"5","key":"i1551-6776-25-7-574-b71","series-title":"Indian Pediatr","first-page":"435","article-title":"Coronavirus disease 2019 (COVID-19) in children: what we know so far and what we do not","volume":"57","year":"2020","unstructured":"Balasubramanian\n S\n , RaoNM, GoenkaA, \n et al. Coronavirus disease 2019 (COVID-19) in children: what we know so far and what we do not. Indian Pediatr. 2020;57(5):435\u2013442."},{"key":"i1551-6776-25-7-574-b72","series-title":"Monatsschr Kinderheilkd","doi-asserted-by":"publisher","DOI":"10.1007\/s00112-020-00919-7","article-title":"COVID-19 in hospitalized children and adolescents [in German] [published online ahead of print April 21, 2020].","unstructured":"Streng\n A\n , HartmannK, ArmannJ, \n et al. COVID-19 in hospitalized children and adolescents [in German] [published online ahead of print April 21, 2020].Monatsschr Kinderheilkd. doi:10.1007\/s00112-020-00919-7"},{"issue":"5","key":"i1551-6776-25-7-574-b73","series-title":"J Formos Med Assoc","first-page":"1000","article-title":"CT chest findings in coronavirus disease-19 (COVID-19)","volume":"119","year":"2020","unstructured":"Lal\n A\n , MishraAK, SahuKK.\n CT chest findings in coronavirus disease-19 (COVID-19). J Formos Med Assoc. 2020;119(5):1000\u20131001."},{"issue":"20","key":"i1551-6776-25-7-574-b74","series-title":"Heart Lung","first-page":"30094","article-title":"An update on CT chest findings in coronavirus disease-19 (COVID-19)","volume":"S0147-9563","year":"2020","unstructured":"Sahu\n KK\n , LalA, MishraAK.\n An update on CT chest findings in coronavirus disease-19 (COVID-19). Heart Lung. 2020;S0147-9563(20):30094\u201330097."},{"issue":"5","key":"i1551-6776-25-7-574-b75","series-title":"Pediatr Pulmonol","first-page":"1169","article-title":"Clinical and CT features in pediatric patients with COVID-19 infection: different points from adults","volume":"55","year":"2020","unstructured":"Xia\n W\n , ShaoJ, GuoY, \n et al. Clinical and CT features in pediatric patients with COVID-19 infection: different points from adults. Pediatr Pulmonol. 2020;55(5):1169\u20131174."},{"issue":"5","key":"i1551-6776-25-7-574-b76","series-title":"Sci China Life Sci","first-page":"706","article-title":"Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China","volume":"63","year":"2020","unstructured":"Hu\n Z\n , SongC, XuC, \n et al. Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China. Sci China Life Sci. 2020;63(5):706\u2013711."},{"issue":"11","key":"i1551-6776-25-7-574-b77","series-title":"J Infec Dis","first-page":"1770","article-title":"Clinical outcomes in 55 patients with severe acute respiratory syndrome coronavirus 2 who were asymptomatic at hospital admission in Shenzhen, China","volume":"221","year":"2020","unstructured":"Wang\n Y\n , LiuY, LiuL, \n et al. Clinical outcomes in 55 patients with severe acute respiratory syndrome coronavirus 2 who were asymptomatic at hospital admission in Shenzhen, China. J Infec Dis. 2020;221(11):1770\u20131774."},{"issue":"15","key":"i1551-6776-25-7-574-b78","series-title":"Clin Infect Dis","first-page":"723","article-title":"Novel coronavirus disease 2019 (COVID-19) pneumonia progression course in 17 discharged patients: comparison of clinical and thin-section computed tomography features during recovery","volume":"71","year":"2020","unstructured":"Han\n X\n , CaoY, JiangN, \n et al. Novel coronavirus disease 2019 (COVID-19) pneumonia progression course in 17 discharged patients: comparison of clinical and thin-section computed tomography features during recovery. Clin Infect Dis. 2020;71(15):723\u2013731."},{"issue":"6","key":"i1551-6776-25-7-574-b79","series-title":"J Clin Microbiol","doi-asserted-by":"publisher","first-page":"e00557-20","DOI":"10.1128\/JCM.00557-20","article-title":"Comparative performance of SARS-CoV-2 detection assays using seven different primer-probe sets and one assay kit","volume":"58","year":"2020","unstructured":"Nalla\n AK\n , CastoAM, HuangM-LW, \n et al. Comparative performance of SARS-CoV-2 detection assays using seven different primer-probe sets and one assay kit. J Clin Microbiol. 2020;58(6):e00557-20. doi: 10.1128\/JCM.00557-20"},{"issue":"8","key":"i1551-6776-25-7-574-b80","series-title":"J Clin Microbiol","doi-asserted-by":"publisher","first-page":"e00821-20","DOI":"10.1128\/JCM.00821-20","article-title":"Comparison of commercially available and laboratory-developed assays for in vitro detection of SARS-CoV-2 in clinical laboratories","volume":"58","year":"2020","unstructured":"Lieberman\n JA\n , PepperG, NaccacheSN, \n et al. Comparison of commercially available and laboratory-developed assays for in vitro detection of SARS-CoV-2 in clinical laboratories. J Clin Microbiol. 2020;58(8):e00821-20. doi: 10.1128\/JCM.00821-20"},{"issue":"18","key":"i1551-6776-25-7-574-b81","series-title":"JAMA","first-page":"1843","article-title":"Detection of SARSCoV-2 in different types of clinical specimens","volume":"323","year":"2020","unstructured":"Wang\n W\n , XuY, GaoR, \n et al. Detection of SARSCoV-2 in different types of clinical specimens. JAMA. 2020;323(18):1843\u20131844."},{"key":"i1551-6776-25-7-574-b82","series-title":"Ann Intern Med","doi-asserted-by":"publisher","DOI":"10.7326\/M20-1495","article-title":"Variation in false-negative rate of reverse transcriptase polymerase chain reaction-based SARS-CoV-2 tests by time since exposure [published online ahead of print May 13, 2020].","unstructured":"Kucirka\n LM\n , LauerSA, LaeyendeckerO, \n et al. Variation in false-negative rate of reverse transcriptase polymerase chain reaction-based SARS-CoV-2 tests by time since exposure [published online ahead of print May 13, 2020].Ann Intern Med. doi:10.7326\/M20-1495"},{"issue":"2","key":"i1551-6776-25-7-574-b83","series-title":"Radiology","first-page":"E32","article-title":"Correlation of chest CT and RT-PCR testing for coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases","volume":"296","year":"2020","unstructured":"Ai\n T\n , YangZ, HouH, \n et al. Correlation of chest CT and RT-PCR testing for coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology. 2020;296(2):E32\u2013E40."},{"key":"i1551-6776-25-7-574-b84","series-title":"MedRxiv.","doi-asserted-by":"publisher","first-page":"20021493","DOI":"10.1101\/2020.02.11.20021493","article-title":"Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infections.","volume":"11","year":"2020","unstructured":"Yang\n Y\n , YangM, ShenC, \n et al. Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infections.Posted online Month day, year. MedRxiv.2020:11:20021493. doi: 10.1101\/2020.02.11.20021493"},{"issue":"546","key":"i1551-6776-25-7-574-b85","series-title":"Sci Transl Med","doi-asserted-by":"publisher","first-page":"eabc1931","DOI":"10.1126\/scitranslmed.abc1931","article-title":"COVID-19 diagnostics in context","volume":"12","year":"2020","unstructured":"Weissleder\n R\n , LeeH, KoJ, PittetMJ.\n COVID-19 diagnostics in context. Sci Transl Med. 2020;12(546):eabc1931. doi:10.1126\/scitranslmed.abc1931"},{"issue":"10237","key":"i1551-6776-25-7-574-b86","series-title":"Lancet.","first-page":"1607","article-title":"Hyperinflammatory shock in children during COVID-19 pandemic","volume":"395","year":"2020","unstructured":"Riphagen\n S\n , GomezX, Gonzalez-MartinezC, \n et al. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet.2020;395(10237):1607\u20131608."},{"issue":"6","key":"i1551-6776-25-7-574-b87","series-title":"Am Fam Physician","first-page":"365","article-title":"Diagnosis and management of Kawasaki disease","volume":"91","year":"2015","unstructured":"Saguil\n A\n , FargoMV, GroganSP.\n Diagnosis and management of Kawasaki disease. Am Fam Physician. 2015;91(6):365\u2013371."},{"key":"i1551-6776-25-7-574-b88","unstructured":"Health Alert Network (HAN):\n \n Multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019.\n Accessed May 15, 2020. https:\/\/emergency.cdc.gov\/han\/2020\/han00432.asp","article-title":"Multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019."},{"issue":"2","key":"i1551-6776-25-7-574-b89","series-title":"Pediatrics","doi-asserted-by":"publisher","first-page":"e20201711","DOI":"10.1542\/peds.2020-1711","article-title":"SARS-CoV-2-induced Kawasaki-like hyperinflammatory syndrome: a novel COVID phenotype in children","volume":"146","year":"2020","unstructured":"Licciardi\n F\n , PruccoliG, DeninaM, \n et al. SARS-CoV-2-induced Kawasaki-like hyperinflammatory syndrome: a novel COVID phenotype in children. Pediatrics. 2020;146(2):e20201711. doi:10.1542\/peds.2020-1711"},{"issue":"10239","key":"i1551-6776-25-7-574-b90","series-title":"Lancet","first-page":"1771","article-title":"An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study","volume":"395","year":"2020","unstructured":"Verdoni\n L\n , MazzaA, GervasoniA, \n et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020;395(10239):1771\u20131778."},{"key":"i1551-6776-25-7-574-b91","series-title":"JAMA","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.10369","article-title":"Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARSCoV-2 [published online ahead of print June 8, 2020]","unstructured":"Whittaker\n E\n , BamfordA, KennyJ, \n et al. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARSCoV-2 [published online ahead of print June 8, 2020]. JAMA. doi:10.1001\/jama.2020.10369"},{"key":"i1551-6776-25-7-574-b92","series-title":"JAMA","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.10374","article-title":"Multisystem inflammatory syndrome related to COVID-19 in previously healthy children and adolescents in New York City [published online ahead of print June 8, 2020].","unstructured":"Cheung\n EW\n , ZachariahP, GorelikM, \n et al. Multisystem inflammatory syndrome related to COVID-19 in previously healthy children and adolescents in New York City [published online ahead of print June 8, 2020].JAMA. doi:10.1001\/jama.2020.10374"},{"key":"i1551-6776-25-7-574-b93","unstructured":"World Health Organization.\n Multisystem inflammatory syndrome in children and adolescents with COVID-19: scientific brief.\n Accessed May 15, 2020. WHO\/2019-nCoV\/Sci_Brief\/Multisystem_Syndrome_Children\/2020.1","article-title":"Multisystem inflammatory syndrome in children and adolescents with COVID-19: scientific brief."},{"key":"i1551-6776-25-7-574-b94","series-title":"Prog Pediatr Cardiol","doi-asserted-by":"publisher","first-page":"101232","DOI":"10.1016\/j. ppedcard.2020.101232","article-title":"COVID-19 associated multisystem inflammatory syndrome in children (MIS-C) guidelines: a Western New York approach","volume":"57","year":"2020","unstructured":"Hennon\n TR\n , PenqueMD, Abdul-AzizR, \n et al. COVID-19 associated multisystem inflammatory syndrome in children (MIS-C) guidelines: a Western New York approach. Prog Pediatr Cardiol. 2020;57:101232. doi: 10.1016\/j. ppedcard.2020.101232"},{"issue":"6","key":"i1551-6776-25-7-574-b95","series-title":"J Med Virol","first-page":"533","article-title":"Latest updates on COVID-2019: a changing paradigm shift","volume":"92","year":"2020","unstructured":"Sahu\n KK\n , LalA, MishraAK.\n Latest updates on COVID-2019: a changing paradigm shift. J Med Virol. 2020;92(6):533\u2013535."},{"issue":"5","key":"i1551-6776-25-7-574-b96","series-title":"J Family Med Prim Care","first-page":"2149","article-title":"Preventive and treatment strategies of COVID-19: from community to clinical trials","volume":"9","year":"2020","unstructured":"Sahu\n KK\n , KumarR.\n Preventive and treatment strategies of COVID-19: from community to clinical trials. J Family Med Prim Care. 2020;9(5):2149\u20132157."},{"key":"i1551-6776-25-7-574-b97","series-title":"Expert Rev Hematol","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/17474086.2020.1787147","article-title":"Managing patients with hematological malignancies during COVID-19 pandemic.","year":"2020","unstructured":"Sahu\n KK\n , CernyJ.\n Managing patients with hematological malignancies during COVID-19 pandemic.\n Expert Rev Hematol. 2020:1\u20137. doi: 10.1080\/17474086.2020.1787147"},{"key":"i1551-6776-25-7-574-b98","series-title":"Blood Cells Mol Dis","doi-asserted-by":"publisher","first-page":"102439","DOI":"10.1016\/j.bcmd.2020.102439","article-title":"Facing COVID-19 in the hematopoietic cell transplant setting: a new challenge for transplantation physicians","volume":"83","year":"2020","unstructured":"Sahu\n KK\n , JindalV, SiddiquiAD, \n et al. Facing COVID-19 in the hematopoietic cell transplant setting: a new challenge for transplantation physicians. Blood Cells Mol Dis. 2020;83:102439. doi:10.1016\/j.bcmd.2020.102439"},{"issue":"8","key":"i1551-6776-25-7-574-b99","series-title":"Mayo Clin Proc","first-page":"1574","article-title":"Innovation lessons from the COVID-19 pandemic","volume":"95","year":"2020","unstructured":"Farrugia\n G\n , PlutowskiRW.\n Innovation lessons from the COVID-19 pandemic. Mayo Clin Proc. 2020;95(8):1574\u20131577."},{"issue":"7","key":"i1551-6776-25-7-574-b100","series-title":"Lancet Child Adolesc Health","first-page":"e17","article-title":"The severity of COVID-19 in children on immunosuppressive medication","volume":"4","year":"2020","unstructured":"Marlais\n M\n , WlodkowskiT, VivarelliM, \n et al. The severity of COVID-19 in children on immunosuppressive medication. Lancet Child Adolesc Health. 2020;4(7):e17\u2013e18."},{"issue":"3","key":"i1551-6776-25-7-574-b101","series-title":"Cell Res","first-page":"269","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","year":"2020","unstructured":"Wang\n M\n , CaoR, ZhangL, \n et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30(3):269\u2013271."},{"article-title":"remdesivir EUA letter of authorization\u2014FDA, California.","year":"2020","key":"i1551-6776-25-7-574-b102","unstructured":"Hinton\n DM.\n \n \n remdesivir EUA letter of authorization\u2014FDA, California.\n 2020. Accessed August 8, 2020. https:\/\/www.fda.gov\/media\/137564\/download"},{"article-title":"Gilead Sciences. Fact sheet for health care providers emergency use authorization (EUA) of Veklury\u00ae (remdesivir)","year":"2020","key":"i1551-6776-25-7-574-b103","unstructured":"Gilead Sciences. Fact sheet for health care providers emergency use authorization (EUA) of Veklury\u00ae (remdesivir). 2020. Accessed August 8, 2020. https:\/\/www.fda.gov\/media\/137566\/download"},{"key":"i1551-6776-25-7-574-b104","series-title":"N Engl J Med","doi-asserted-by":"publisher","DOI":"10.1056\/NEJ-Moa2007764","article-title":"Remdesivir for the treatment of Covid-19: preliminary report [published online ahead of print May 22, 2020].","unstructured":"Beigel\n JH\n , TomashekKM, DoddLE, ; ACTT-1 Study Group Members.\n Remdesivir for the treatment of Covid-19: preliminary report [published online ahead of print May 22, 2020].\n N Engl J Med. doi:10.1056\/NEJ-Moa2007764"},{"issue":"10236","key":"i1551-6776-25-7-574-b105","series-title":"Lancet","first-page":"1569","article-title":"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial [correction in: Lancet. 2020;395(10238):1694]","volume":"395","year":"2020","unstructured":"Wang\n Y\n , ZhangD, DuG, \n et al. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial [correction in: Lancet. 2020;395(10238):1694]. Lancet. 2020;395(10236):1569\u20131578."},{"issue":"22","key":"i1551-6776-25-7-574-b106","series-title":"Chem Asian J","first-page":"3962","article-title":"New nucleoside analogues for the treatment of hemorrhagic fever virus infections","volume":"14","year":"2019","unstructured":"De Clercq\n E.\n \n \n New nucleoside analogues for the treatment of hemorrhagic fever virus infections. Chem Asian J. 2019;14(22):3962\u20133968."},{"key":"i1551-6776-25-7-574-b107","series-title":"Engineering (Beijing)","doi-asserted-by":"publisher","DOI":"10.1016\/j.eng.2020.03.007","article-title":"Experimental treatment with Favipiravir for COVID-19: an open-label control study [published online ahead of print March 18, 2020].","unstructured":"Cai\n Q\n , YangM, LiuD, \n et al. Experimental treatment with Favipiravir for COVID-19: an open-label control study [published online ahead of print March 18, 2020].Engineering (Beijing). doi:10.1016\/j.eng.2020.03.007"},{"issue":"15","key":"i1551-6776-25-7-574-b108","series-title":"Clin Infect Dis","first-page":"732","article-title":"In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","volume":"71","year":"2020","unstructured":"Yao\n X\n , YeF, ZhangM, \n et al. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2020;71(15):732\u2013739."},{"issue":"1","key":"i1551-6776-25-7-574-b109","series-title":"Int J Antimicrob Agents","doi-asserted-by":"publisher","first-page":"105949","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","volume":"56","year":"2020","unstructured":"Gautret\n P\n , LagierJ-C, ParolaP, \n et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020;56(1):105949. doi:10.1016\/j.ijantimicag.2020.105949"},{"key":"i1551-6776-25-7-574-b110","series-title":"Heart Lung","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrtlng.2020.04.014","article-title":"India fights back: COVID-19 pandemic [published online ahead of print April 23, 2020].","unstructured":"Sahu\n KK\n , MishraAK, LalA, \n et al. India fights back: COVID-19 pandemic [published online ahead of print April 23, 2020].Heart Lung. doi:10.1016\/j.hrtlng.2020.04.014"},{"article-title":"No clinical benefit from use of hydroxychloroquine in hospitalised patients with COVID-19.","year":"2020","key":"i1551-6776-25-7-574-b111","unstructured":"Horby\n P\n , LandrayM.\n No clinical benefit from use of hydroxychloroquine in hospitalised patients with COVID-19.\n 2020. Accessed August 8, 2020. https:\/\/www.recovery-trial.net\/news\/statement-from-the-chief-investigators-of-the-randomised-evaluation-of-covid-19-therapy-recovery-trial-on-hydroxychloroquine-5-june-2020-no-clinical-benefit-from-use-of-hydroxychloroquine-in-hospitalised-patients-with-covid-19"},{"key":"i1551-6776-25-7-574-b112","series-title":"J Med Virol","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25847","article-title":"Patterns of heart injury in COVID\u201319 and relation to outcome [published online ahead of print April 8, 2020].","unstructured":"Mishra\n AK\n , SahuKK, LalA, \n et al. Patterns of heart injury in COVID\u201319 and relation to outcome [published online ahead of print April 8, 2020].J Med Virol. doi:10.1002\/jmv.25847"},{"issue":"25","key":"i1551-6776-25-7-574-b113","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1056\/NEJMoa2007621","article-title":"Cardiovascular disease, drug therapy, and mortality in Covid-19 [retracted in: N Engl J Med. 2020;382:2582. doi: 10.1056\/NEJMc2021225]","volume":"382","year":"2020","unstructured":"Mehra\n MR\n , DesaiSS, KuyS, \n et al. Cardiovascular disease, drug therapy, and mortality in Covid-19 [retracted in: N Engl J Med. 2020;382:2582. doi: 10.1056\/NEJMc2021225]. N Engl J Med. 2020;382(25):e102. doi:10.1056\/NEJMoa2007621"},{"issue":"10240","key":"i1551-6776-25-7-574-b114","series-title":"Lancet","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1016\/S0140-6736(20)31324-6","article-title":"Retraction\u2014Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis [retraction of: Mehra MR, Ruschitzka F, Patel AN. In: Lancet.; 2020 May 22:S0140-6736(20)31180-6. doi: 10.1016\/S0140-6736(20)31180-6]","volume":"395","year":"2020","unstructured":"Mehra\n MR\n , RuschitzkaF, PatelAN.\n Retraction\u2014Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis [retraction of: Mehra MR, Ruschitzka F, Patel AN. In: Lancet.; 2020 May 22:S0140-6736(20)31180-6. doi: 10.1016\/S0140-6736(20)31180-6]. Lancet. 2020;395(10240):1820. doi:10.1016\/S0140-6736(20)31324-6"},{"issue":"3","key":"i1551-6776-25-7-574-b115","series-title":"Lancet Infect Dis","first-page":"147","article-title":"Treatment and vaccines for severe acute respiratory syndrome","volume":"5","year":"2005","unstructured":"Groneberg\n DA\n ,PoutanenSM, LowDE, \n et al. Treatment and vaccines for severe acute respiratory syndrome. Lancet Infect Dis. 2005;5(3):147\u2013155."},{"issue":"19","key":"i1551-6776-25-7-574-b116","series-title":"New Engl J Med","first-page":"1787","article-title":"A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19","volume":"382","year":"2020","unstructured":"Cao\n B\n , WangY, WenD, \n et al. A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19. New Engl J Med. 2020;382(19):1787\u20131799."},{"issue":"10238","key":"i1551-6776-25-7-574-b117","series-title":"Lancet","first-page":"1695","article-title":"Triple combination of interferon beta-1b, lopinavir\u2013ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial","volume":"395","year":"2020","unstructured":"Hung\n IF-N\n , LungK-C, TsoEY-K, \n et al. Triple combination of interferon beta-1b, lopinavir\u2013ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. Lancet. 2020;395(10238):1695\u2013704."},{"issue":"3","key":"i1551-6776-25-7-574-b118","series-title":"Thorax","first-page":"252","article-title":"Role of lopinavir\/ritonavir in the treatment of SARS: initial virological and clinical findings","volume":"59","year":"2004","unstructured":"Chu\n CM\n , ChengVCC, HungIFN, \n et al. Role of lopinavir\/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax. 2004;59(3):252\u2013256."},{"key":"i1551-6776-25-7-574-b119","series-title":"J Med Virol","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26047","article-title":"Convalescent plasma therapy: a passive therapy for an aggressive COVID-19 [published online ahead of print May 21, 2020].","unstructured":"Sahu\n KK\n , JindalV, SiddiquiAD, \n et al. Convalescent plasma therapy: a passive therapy for an aggressive COVID-19 [published online ahead of print May 21, 2020].J Med Virol. doi:10.1002\/jmv.26047"},{"issue":"5","key":"i1551-6776-25-7-574-b120","series-title":"JAMA","first-page":"1","article-title":"Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19: a randomized clinical trial","volume":"324","year":"2020","unstructured":"Li\n L\n , ZhangW, HuY, \n et al. Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19: a randomized clinical trial. JAMA. 2020;324(5):1\u201311."},{"issue":"8","key":"i1551-6776-25-7-574-b121","series-title":"Am J Pathol","first-page":"1680","article-title":"Treatment of COVID-19 patients with convalescent plasma","volume":"190","year":"2020","unstructured":"Salazar\n E\n , PerezKK, AshrafM, \n et al. Treatment of COVID-19 patients with convalescent plasma. Am J Pathol. 2020;190(8):1680\u20131690."},{"key":"i1551-6776-25-7-574-b122","series-title":"JAMA","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.10218","article-title":"A randomized trial of convalescent plasma for COVID-19\u2014potentially hopeful signals [published online ahead of print June 3, 2020].","unstructured":"Casadevall\n A\n , JoynerMJ, PirofskiLA.\n A randomized trial of convalescent plasma for COVID-19\u2014potentially hopeful signals [published online ahead of print June 3, 2020].\n JAMA. doi:10.1001\/jama.2020.10218"},{"issue":"10223","key":"i1551-6776-25-7-574-b123","series-title":"Lancet","first-page":"473","article-title":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury","volume":"395","year":"2020","unstructured":"Russell\n CD\n , MillarJE, BaillieJK.\n Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet. 2020;395(10223):473\u2013475."},{"key":"i1551-6776-25-7-574-b124","series-title":"N Engl J Med","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with Covid-19: preliminary report [published online ahead of print July 17, 2020].","unstructured":"Horby\n P\n , LimWS, EmbersonJ, \n et al. Dexamethasone in hospitalized patients with Covid-19: preliminary report [published online ahead of print July 17, 2020].N Engl J Med. doi:10.1056\/NEJMoa2021436"},{"issue":"3","key":"i1551-6776-25-7-574-b125","series-title":"Clin Exp Rheumatol","first-page":"529","article-title":"Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in severe patients with COVID-19","volume":"38","year":"2020","unstructured":"Sciascia\n S\n , Apr\u00e0F, BaffaA, \n et al. Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in severe patients with COVID-19. Clin Exp Rheumatol. 2020;38(3):529\u2013532."},{"issue":"6","key":"i1551-6776-25-7-574-b126","series-title":"Lancet Rheumatol","first-page":"e325","article-title":"Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study","volume":"2","year":"2020","unstructured":"Cavalli\n G\n , De LucaG, CampochiaroC, \n et al. Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study. Lancet Rheumatol. 2020;2(6):e325\u2013e331."},{"issue":"21","key":"i1551-6776-25-7-574-b127","series-title":"Blood","first-page":"1912","article-title":"The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19-infected patients","volume":"135","year":"2020","unstructured":"Treon\n SP\n , CastilloJJ, SkarbnikAP, \n et al. The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19-infected patients. Blood. 2020;135(21):1912\u20131915."},{"issue":"2","key":"i1551-6776-25-7-574-b128","series-title":"J Infect","first-page":"318","article-title":"Baricitinib therapy in COVID-19: a pilot study on safety and clinical impact","volume":"81","year":"2020","unstructured":"Cantini\n F\n , NiccoliL, MatarreseD, \n et al. Baricitinib therapy in COVID-19: a pilot study on safety and clinical impact. J Infect. 2020;81(2):318\u2013356."},{"issue":"7","key":"i1551-6776-25-7-574-b129","series-title":"Eur Rev Med Pharmacol Sci","first-page":"4040","article-title":"Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experience","volume":"24","year":"2020","unstructured":"Diurno\n F\n , NumisFG, PortaG, \n et al. Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experience. Eur Rev Med Pharmacol Sci. 2020;24(7):4040\u20134047."},{"issue":"1","key":"i1551-6776-25-7-574-b130","series-title":"Nat Commun","first-page":"1","article-title":"A human monoclonal antibody blocking SARS-CoV-2 infection","volume":"11","year":"2020","unstructured":"Wang\n C\n , LiW, DrabekD, \n et al. A human monoclonal antibody blocking SARS-CoV-2 infection. Nat Commun. 2020;11(1):1\u20136."},{"issue":"8","key":"i1551-6776-25-7-574-b131","series-title":"Ann Pharmacother","first-page":"820","article-title":"Myth busters: dietary supplements and COVID-19","volume":"54","year":"2020","unstructured":"Adams\n KK\n , BakerWL, SobierajDM.\n Myth busters: dietary supplements and COVID-19. Ann Pharmacother. 2020;54(8):820\u2013826."},{"issue":"5","key":"i1551-6776-25-7-574-b132","series-title":"Nat Rev Drug Discov","first-page":"305","article-title":"The COVID-19 vaccine development landscape","volume":"19","year":"2020","unstructured":"Le\n TT\n , AndreadakisZ, KumarA, \n et al. The COVID-19 vaccine development landscape. Nat Rev Drug Discov. 2020;19(5):305\u2013306."},{"article-title":"DRAFT landscape of COVID-19 candidate vaccines.","year":"2020","key":"i1551-6776-25-7-574-b133","unstructured":"World Health Organization.\n DRAFT landscape of COVID-19 candidate vaccines.\n 2020. Accessed June 28, 2020. https:\/\/www.who.int\/publications\/m\/item\/draft-landscape-of-covid-19-candidate-vaccines"},{"key":"i1551-6776-25-7-574-b134","unstructured":"Coalition of Epidemic Preparedness [CEPI].\n Accessed June 29, 2020. s-of-covid-19-vaccine\/https:\/\/cepi.net\/news_cepi\/cepi-partners-with-astrazeneca-to-manufacture-300-million-globally-accessible-dose"}],"container-title":["The Journal of Pediatric Pharmacology and Therapeutics"],"original-title":[],"link":[{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/25\/7\/article-p574.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/meridian.allenpress.com\/jppt\/article-pdf\/25\/7\/574\/2605788\/1551-6776-25_7_574.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/25\/7\/article-p574.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/25\/7\/article-p574.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:40:18Z","timestamp":1747356018000},"score":1,"resource":{"primary":{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/25\/7\/article-p574.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":134,"journal-issue":{"issue":"7"},"URL":"https:\/\/doi.org\/10.5863\/1551-6776-25.7.574","relation":{},"ISSN":["1551-6776"],"issn-type":[{"type":"print","value":"1551-6776"}],"subject":[],"published":{"date-parts":[[2020,9]]}}}